Akero Therapeutics Inc (AKRO)
42.72
-0.86
(-1.97%)
USD |
NASDAQ |
Mar 28, 16:00
42.70
-0.02
(-0.05%)
After-Hours: 20:00
Akero Therapeutics Enterprise Value: 2.694B for March 28, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| 89bio Inc | 775.33M |
| Biogen Inc | 24.17B |
| Cytokinetics Inc | 4.695B |
| Sage Therapeutics Inc | 4.644M |
| Allakos Inc | -60.06M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -70.02M |
| Total Expenses (Quarterly) | 78.02M |
| EPS Diluted (Quarterly) | -0.99 |
| Earnings Yield | -8.78% |